drugset / Trial / NCT03272711

Remediation of Age-related Cognitive Decline: Vortioxetine and Cognitive Training

NCT03272711

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this research study is to examine the potential benefits of vortioxetine in combination with at-home computerized cognitive training program to improve cognition, such as memory, attention, and concentration. This study will compare the effectiveness of vortioxetine plus cognitive training versus placebo plus cognitive training.

Timeline

Start
2016-08-31
Primary completion
2019-01-24
Completion
2019-01-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Vortioxetine Unknown 10 mg